肝性脳症治療薬の世界市場

【英語タイトル】Global Hepatic Encephalopathy Drug Market Research Report 2017

QYResearchが出版した調査資料(QYR802A2523)・商品コード:QYR802A2523
・発行会社(調査会社):QYResearch
・発行日:2018年1月1日
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD5,800 ⇒換算¥655,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界の肝性脳症治療薬市場について調査・分析し、肝性脳症治療薬の世界市場概観、肝性脳症治療薬の種類別市場分析、用途別市場分析、肝性脳症治療薬の世界市場規模予測、関連企業分析、主要地域別分析(北米市場、ヨーロッパ市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・肝性脳症治療薬の世界市場概観
・肝性脳症治療薬の種類別市場規模
・肝性脳症治療薬の用途別市場規模
・肝性脳症治療薬の世界市場規模
・肝性脳症治療薬の世界市場規模予測
・肝性脳症治療薬の主要地域別市場規模
・肝性脳症治療薬の北米市場規模・予測
・肝性脳症治療薬のヨーロッパ市場規模・予測
・肝性脳症治療薬の中国市場規模・予測
・肝性脳症治療薬の日本市場規模・予測
・肝性脳症治療薬のアジア市場規模・予測
・肝性脳症治療薬の製造メーカー分析
・肝性脳症治療薬のメーカー別生産量
・肝性脳症治療薬のメーカー別市場シェア
・肝性脳症治療薬の価格動向・価格分析
・肝性脳症治療薬の販売(売上高)動向
・肝性脳症治療薬の貿易(輸出・輸入)動向
・肝性脳症治療薬の産業チェーン分析
・肝性脳症治療薬のマーケティング戦略分析
・肝性脳症治療薬の販売業者(代理店)リスト
・肝性脳症治療薬の市場環境分析
...
【レポートの概要】

In this report, the global Hepatic Encephalopathy Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hepatic Encephalopathy Drug in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Hepatic Encephalopathy Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Alfa Wassermann S.p.A
Cosmo Pharmaceuticals S.p.A
Horizon Pharma Plc
KannaLife Sciences, Inc.
Ocera Therapeutics, Inc.
Rebiotix Inc.
Spherium Biomed S.L.
Umecrine Cognition AB
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
RBX-2660
KLS-13019
GR-3027
SYNB-1020
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Clinic
Hospital
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Hepatic Encephalopathy Drug Market Research Report 2017
1 Hepatic Encephalopathy Drug Market Overview
1.1 Product Overview and Scope of Hepatic Encephalopathy Drug
1.2 Hepatic Encephalopathy Drug Segment by Type (Product Category)
1.2.1 Global Hepatic Encephalopathy Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Hepatic Encephalopathy Drug Production Market Share by Type (Product Category) in 2016
1.2.3 RBX-2660
1.2.4 KLS-13019
1.2.5 GR-3027
1.2.6 SYNB-1020
1.2.7 Others
1.3 Global Hepatic Encephalopathy Drug Segment by Application
1.3.1 Hepatic Encephalopathy Drug Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Hepatic Encephalopathy Drug Market by Region (2012-2022)
1.4.1 Global Hepatic Encephalopathy Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Hepatic Encephalopathy Drug (2012-2022)
1.5.1 Global Hepatic Encephalopathy Drug Revenue Status and Outlook (2012-2022)
1.5.2 Global Hepatic Encephalopathy Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Hepatic Encephalopathy Drug Market Competition by Manufacturers
2.1 Global Hepatic Encephalopathy Drug Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Hepatic Encephalopathy Drug Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Hepatic Encephalopathy Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Hepatic Encephalopathy Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Hepatic Encephalopathy Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Hepatic Encephalopathy Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Hepatic Encephalopathy Drug Market Competitive Situation and Trends
2.5.1 Hepatic Encephalopathy Drug Market Concentration Rate
2.5.2 Hepatic Encephalopathy Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Hepatic Encephalopathy Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Hepatic Encephalopathy Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Hepatic Encephalopathy Drug Production and Market Share by Region (2012-2017)
3.3 Global Hepatic Encephalopathy Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Hepatic Encephalopathy Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Hepatic Encephalopathy Drug Consumption by Region (2012-2017)
4.2 North America Hepatic Encephalopathy Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Hepatic Encephalopathy Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Hepatic Encephalopathy Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Hepatic Encephalopathy Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Hepatic Encephalopathy Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Hepatic Encephalopathy Drug Production, Consumption, Export, Import (2012-2017)

5 Global Hepatic Encephalopathy Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Hepatic Encephalopathy Drug Production and Market Share by Type (2012-2017)
5.2 Global Hepatic Encephalopathy Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Hepatic Encephalopathy Drug Price by Type (2012-2017)
5.4 Global Hepatic Encephalopathy Drug Production Growth by Type (2012-2017)

6 Global Hepatic Encephalopathy Drug Market Analysis by Application
6.1 Global Hepatic Encephalopathy Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Hepatic Encephalopathy Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Hepatic Encephalopathy Drug Manufacturers Profiles/Analysis
7.1 Alfa Wassermann S.p.A
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Cosmo Pharmaceuticals S.p.A
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Horizon Pharma Plc
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Horizon Pharma Plc Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 KannaLife Sciences, Inc.
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Ocera Therapeutics, Inc.
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Rebiotix Inc.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Rebiotix Inc. Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Spherium Biomed S.L.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Spherium Biomed S.L. Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Umecrine Cognition AB
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Hepatic Encephalopathy Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Umecrine Cognition AB Hepatic Encephalopathy Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview

8 Hepatic Encephalopathy Drug Manufacturing Cost Analysis
8.1 Hepatic Encephalopathy Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hepatic Encephalopathy Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Hepatic Encephalopathy Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hepatic Encephalopathy Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Hepatic Encephalopathy Drug Market Forecast (2017-2022)
12.1 Global Hepatic Encephalopathy Drug Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Hepatic Encephalopathy Drug Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Hepatic Encephalopathy Drug Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Hepatic Encephalopathy Drug Price and Trend Forecast (2017-2022)
12.2 Global Hepatic Encephalopathy Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Hepatic Encephalopathy Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Hepatic Encephalopathy Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Hepatic Encephalopathy Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Hepatic Encephalopathy Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Hepatic Encephalopathy Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Hepatic Encephalopathy Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Hepatic Encephalopathy Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Hepatic Encephalopathy Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

List of Tables and Figures

Figure Picture of Hepatic Encephalopathy Drug
Figure Global Hepatic Encephalopathy Drug Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Hepatic Encephalopathy Drug Production Market Share by Types (Product Category) in 2016
Figure Product Picture of RBX-2660
Table Major Manufacturers of RBX-2660
Figure Product Picture of KLS-13019
Table Major Manufacturers of KLS-13019
Figure Product Picture of GR-3027
Table Major Manufacturers of GR-3027
Figure Product Picture of SYNB-1020
Table Major Manufacturers of SYNB-1020
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Hepatic Encephalopathy Drug Consumption (K Pcs) by Applications (2012-2022)
Figure Global Hepatic Encephalopathy Drug Consumption Market Share by Applications in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Hepatic Encephalopathy Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Hepatic Encephalopathy Drug Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Hepatic Encephalopathy Drug Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Hepatic Encephalopathy Drug Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Hepatic Encephalopathy Drug Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Hepatic Encephalopathy Drug Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Hepatic Encephalopathy Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Hepatic Encephalopathy Drug Major Players Product Production (K Pcs) (2012-2017)
Table Global Hepatic Encephalopathy Drug Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Hepatic Encephalopathy Drug Production Share by Manufacturers (2012-2017)
Figure 2016 Hepatic Encephalopathy Drug Production Share by Manufacturers
Figure 2017 Hepatic Encephalopathy Drug Production Share by Manufacturers
Figure Global Hepatic Encephalopathy Drug Major Players Product Revenue (Million USD) (2012-2017)
Table Global Hepatic Encephalopathy Drug Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Hepatic Encephalopathy Drug Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Hepatic Encephalopathy Drug Revenue Share by Manufacturers
Table 2017 Global Hepatic Encephalopathy Drug Revenue Share by Manufacturers
Table Global Market Hepatic Encephalopathy Drug Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Hepatic Encephalopathy Drug Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Hepatic Encephalopathy Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Hepatic Encephalopathy Drug Product Category
Figure Hepatic Encephalopathy Drug Market Share of Top 3 Manufacturers
Figure Hepatic Encephalopathy Drug Market Share of Top 5 Manufacturers
Table Global Hepatic Encephalopathy Drug Capacity (K Pcs) by Region (2012-2017)
Figure Global Hepatic Encephalopathy Drug Capacity Market Share by Region (2012-2017)
Figure Global Hepatic Encephalopathy Drug Capacity Market Share by Region (2012-2017)
Figure 2016 Global Hepatic Encephalopathy Drug Capacity Market Share by Region
Table Global Hepatic Encephalopathy Drug Production by Region (2012-2017)
Figure Global Hepatic Encephalopathy Drug Production (K Pcs) by Region (2012-2017)
Figure Global Hepatic Encephalopathy Drug Production Market Share by Region (2012-2017)
Figure 2016 Global Hepatic Encephalopathy Drug Production Market Share by Region
Table Global Hepatic Encephalopathy Drug Revenue (Million USD) by Region (2012-2017)
Table Global Hepatic Encephalopathy Drug Revenue Market Share by Region (2012-2017)
Figure Global Hepatic Encephalopathy Drug Revenue Market Share by Region (2012-2017)
Table 2016 Global Hepatic Encephalopathy Drug Revenue Market Share by Region
Figure Global Hepatic Encephalopathy Drug Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Hepatic Encephalopathy Drug Consumption (K Pcs) Market by Region (2012-2017)
Table Global Hepatic Encephalopathy Drug Consumption Market Share by Region (2012-2017)
Figure Global Hepatic Encephalopathy Drug Consumption Market Share by Region (2012-2017)
Figure 2016 Global Hepatic Encephalopathy Drug Consumption (K Pcs) Market Share by Region
Table North America Hepatic Encephalopathy Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Hepatic Encephalopathy Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Hepatic Encephalopathy Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Hepatic Encephalopathy Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Hepatic Encephalopathy Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Hepatic Encephalopathy Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Hepatic Encephalopathy Drug Production (K Pcs) by Type (2012-2017)
Table Global Hepatic Encephalopathy Drug Production Share by Type (2012-2017)
Figure Production Market Share of Hepatic Encephalopathy Drug by Type (2012-2017)
Figure 2016 Production Market Share of Hepatic Encephalopathy Drug by Type
Table Global Hepatic Encephalopathy Drug Revenue (Million USD) by Type (2012-2017)
Table Global Hepatic Encephalopathy Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Hepatic Encephalopathy Drug by Type (2012-2017)
Figure 2016 Revenue Market Share of Hepatic Encephalopathy Drug by Type
Table Global Hepatic Encephalopathy Drug Price (USD/Pcs) by Type (2012-2017)
Figure Global Hepatic Encephalopathy Drug Production Growth by Type (2012-2017)
Table Global Hepatic Encephalopathy Drug Consumption (K Pcs) by Application (2012-2017)
Table Global Hepatic Encephalopathy Drug Consumption Market Share by Application (2012-2017)
Figure Global Hepatic Encephalopathy Drug Consumption Market Share by Applications (2012-2017)
Figure Global Hepatic Encephalopathy Drug Consumption Market Share by Application in 2016
Table Global Hepatic Encephalopathy Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Hepatic Encephalopathy Drug Consumption Growth Rate by Application (2012-2017)
Table Alfa Wassermann S.p.A Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production Growth Rate (2012-2017)
Figure Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production Market Share (2012-2017)
Figure Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Revenue Market Share (2012-2017)
Table Cosmo Pharmaceuticals S.p.A Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production Growth Rate (2012-2017)
Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production Market Share (2012-2017)
Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Revenue Market Share (2012-2017)
Table Horizon Pharma Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Production Growth Rate (2012-2017)
Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Production Market Share (2012-2017)
Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Revenue Market Share (2012-2017)
Table KannaLife Sciences, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production Growth Rate (2012-2017)
Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production Market Share (2012-2017)
Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Revenue Market Share (2012-2017)
Table Ocera Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production Growth Rate (2012-2017)
Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production Market Share (2012-2017)
Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Revenue Market Share (2012-2017)
Table Rebiotix Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rebiotix Inc. Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Rebiotix Inc. Hepatic Encephalopathy Drug Production Growth Rate (2012-2017)
Figure Rebiotix Inc. Hepatic Encephalopathy Drug Production Market Share (2012-2017)
Figure Rebiotix Inc. Hepatic Encephalopathy Drug Revenue Market Share (2012-2017)
Table Spherium Biomed S.L. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Production Growth Rate (2012-2017)
Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Production Market Share (2012-2017)
Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Revenue Market Share (2012-2017)
Table Umecrine Cognition AB Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Production Growth Rate (2012-2017)
Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Production Market Share (2012-2017)
Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatic Encephalopathy Drug
Figure Manufacturing Process Analysis of Hepatic Encephalopathy Drug
Figure Hepatic Encephalopathy Drug Industrial Chain Analysis
Table Raw Materials Sources of Hepatic Encephalopathy Drug Major Manufacturers in 2016
Table Major Buyers of Hepatic Encephalopathy Drug
Table Distributors/Traders List
Figure Global Hepatic Encephalopathy Drug Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Hepatic Encephalopathy Drug Price (Million USD) and Trend Forecast (2017-2022)
Table Global Hepatic Encephalopathy Drug Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Hepatic Encephalopathy Drug Production Market Share Forecast by Region (2017-2022)
Table Global Hepatic Encephalopathy Drug Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Hepatic Encephalopathy Drug Consumption Market Share Forecast by Region (2017-2022)
Figure North America Hepatic Encephalopathy Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Hepatic Encephalopathy Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Hepatic Encephalopathy Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Hepatic Encephalopathy Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Hepatic Encephalopathy Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Hepatic Encephalopathy Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Hepatic Encephalopathy Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Hepatic Encephalopathy Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Hepatic Encephalopathy Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Hepatic Encephalopathy Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Hepatic Encephalopathy Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Hepatic Encephalopathy Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Hepatic Encephalopathy Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Hepatic Encephalopathy Drug Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Hepatic Encephalopathy Drug Production (K Pcs) Forecast by Type (2017-2022)
Table Global Hepatic Encephalopathy Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Hepatic Encephalopathy Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Hepatic Encephalopathy Drug Price Forecast by Type (2017-2022)
Table Global Hepatic Encephalopathy Drug Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Hepatic Encephalopathy Drug Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source


★調査レポート[肝性脳症治療薬の世界市場] (コード:QYR802A2523)販売に関する免責事項を必ずご確認ください。
★調査レポート[肝性脳症治療薬の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆